Search Results - "ANARGYROU, K"

Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid by Terpos, E., Christoulas, D., Kokkoris, P., Anargyrou, K., Gavriatopoulou, M., Migkou, M., Tsionos, K., Dimopoulos, M.A.

Get full text

PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB‐CHOP (RCHOP) ± RADIOTHERAPY (RT) by Vassilakopoulos, T.P., Papageorgiou, S.G., Michail, M., Angelopoulou, M.K., Kourti, G., Kalpadakis, C., Kotsopoulou, M., Leonidopoulou, T., Konstantinidou, P., Kotsianidis, I., Boutsis, D., Michali, E., Sachanas, S., Terpos, E., Karianakis, G., Poziopoulos, C., Vadikolia, C., Pigaditou, A., Vrakidou, E., Anargyrou, K., Symeonidis, A., Stefanoudaki, E., Hadjiharissi, E., Papaioannou, M., Gainaru, G., Tsirogianni, M., Katodritou, E., Karmiris, T., Variami, E., Pappa, V., Dimopoulos, M., Roussou, P., Panayitidis, P., Konstantopoulos, K., Pangalis, G.A.

Get full text

Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study by KORKOLOPOULOU, P, VINIOU, N, ANDROULAKI, A, DAVARIS, P, YATAGANAS, X, KAVANTZA, N, PATSOURIS, E, THYMARA, I, PAVLOPOULOS, P. M, TERPOS, E, STAMATOPOULOS, K, PLATA, E, ANARGYROU, K

“…Various morphometric characteristics of microvessels, highlighted by means of anti-CD34 immunohistochemical staining, were evaluated in the bone marrow of 52…”
Get full text

Low bone mineral density and high bone turnover in patients with non-Hodgkin's lymphoma (NHL) who receive frontline therapy: Results of a multicenter prospective study by Anargyrou, K, Vassilakopoulos, T.P, Tsionos, K, Kokkoris, P, Boutsikas, G, Angelopoulou, M.K, Christoulas, D, Masouridou, S, Gkotzamanidou, M, Dimou, M, Papatheodorou, A, Chatzifotiadis, D.N, Panayiotidis, P, Pangalis, G.A, Meletis, J, Terpos, E

Get full text

Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications by KORKOLOPOULOU, P, THYMARA, I, TSENGA, A, ANDROULAKI, A, DOUSSIS-ANAGNOSTOPOULOU, I. A, PATSOURIS, E, PANGALIS, G. A, KAVANTZAS, N, VASSILAKOPOULOS, T. P, ANGELOPOULOU, M. K, KOKORIS, S. I, DIMITRIADOU, E. M, SIAKANTARIS, M. P, ANARGYROU, K, PANAYIOTIDIS, P

“…The significance of angiogenesis in Hodgkin's lymphoma (HL) is not well defined. The aim of this study was to evaluate various morphometric characteristics of…”
Get full text

Assessment of Procalcitonin as a Diagnostic Marker of Underlying Infection in Patients with Febrile Neutropenia by Giamarellos-Bourboulis, Evangelos J., Grecka, Paraskevi, Poulakou, Garyfallia, Anargyrou, Konstantinos, Katsilambros, Nikolaos, Giamarellou, Helen

“…The novel inflammatory marker procalcitonin (PCT) was assessed as an index of infection in patients with febrile neutropenia. Blood samples were obtained from…”
Get full text

Pulmonary Balantidium coli infection in a leukemic patient by Anargyrou, K., Petrikkos, G.L., Suller, M.T.E., Skiada, A., Siakantaris, M.P., Osuntoyinbo, R.T., Pangalis, G., Vaiopoulos, G.

“…A 59‐year‐old woman suffering from chronic lymphocytic leukemia developed pulmonary lesions; bronchoalveolar lavage was performed for possible systemic fungal…”
Get full text

An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia by Anargyrou, K., Paterakis, G., Boutsis, D., Politou, M., Papadhimitriou, S. I., Siakandaris, M., Vassiliadis, J., Androulakis, A., Meletis, J., Rombos, J., Tassiopoulou, A., Vaiopoulos, G.

“…: Type 2 dendritic cell (DC2) acute leukemia has been recently described. We report here an unusual case of a 17‐yr‐old adolescent with overlapping features of…”
Get full text

Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma by Terpos, Evangelos, Palermos, John, Tsionos, Konstantinos, Anargyrou, Konstantinos, Viniou, Nora, Papassavas, Pantelis, Meletis, John C., Yataganas, Xenophon

“…: Aim: Bisphosphonates are potent inhibitors of osteoclastic activity and are used in the treatment of multiple myeloma (MM) in combination with chemotherapy…”
Get full text

Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites by Vassilakopoulos, T.P., Angelopoulou, M.K., Siakantaris, M.P., Kontopidou, F.N., Dimopoulou, M.N., Barbounis, A., Grigorakis, V., Karkantaris, C., Anargyrou, K., Chatziioannou, M., Rombos, J., Boussiotis, V.A., Vaiopoulos, G., Kittas, C., Pangalis, G.A.

“…: Background: Advanced Hodgkin's lymphoma (HL) is curable by conventional chemotherapy in 60–70% of patients. The pretreatment identification of a sizeable…”
Get full text

Transient monoclonal hypergammaglobulinemia during the course of a rickettsia infection by Vaiopoulos, G, Sideris, P, Anargyrou, K, Melas, P, Plessas, N, Konstantopoulos, K

Get full text

Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration by Terpos, Evangelos, Katodritou, Eirini, Tsiftsakis, Evangelos, Kastritis, Efstathios, Christoulas, Dimitrios, Pouli, Anastasia, Michalis, Eurydiki, Verrou, Evgenia, Anargyrou, Konstantinos, Tsionos, Konstantinos, Dimopoulos, Meletios A, Zervas, Konstantinos

“…On behalf of the Greek Myeloma Study Group Correspondence: Evangelos Terpos, Department of Hematology and Medical Research, 251 General Air Force Hospital, 3…”
Get full text

Gain, but what, how much and at what cost? by Schrijvers, Dirk

Get full text

Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib by Anargyrou, Konstantinos, Terpos, Evangelos, Vassilakopoulos, Theodoros P, Pouli, Anastasia, Sachanas, Sotirios, Tzenou, Tatiana, Masouridis, Stavroula, Christoulas, Dimitrios, Angelopoulou, Maria K, Dimitriadou, Evangelia M, Kalpadakis, Christina, Tsionos, Konstantinos, Panayiotidis, Panayiotis, Dimopoulos, Meletios A, Pangalis, Gerassimos A, Kyrtsonis, Marie-Christine, on behalf of Greek Myeloma Study Group

“…1 Department of Haematology, 251 General Air Force Hospital, Athens 2 Department of Haematology, National and Kapodistrian University of Athens’ School of…”
Get full text

Increased Osteoprotegerin Levels in Response to Increased Bone Resorption in AL Amyloidosis: Comparisons with Bone Remodeling of Multiple Myeloma by Kastritis, E., Dimopoulos, Meletios Athanasios, Mihail, M., Mihali, E., Kyrtsonis, M.C., Delimpassi, S., Katodritou, E., Anagnostopoulos, N., Kokkini, G., Zervas, K., Anargyrou, K., Panagiotidis, P., Terpos, E.

“…Primary systemic amyloidosis (AL) and multiple myeloma (MM) are both clonal plasma cell disorders with distinct clinical characteristics. Bone disease is a…”
Get full text

Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma by Vassilakopoulos, Theodoros P, Angelopoulou, Maria K, Siakantaris, Marina P, Kontopidou, Flora N, Dimopoulou, Maria N, Kokoris, Styliani I, Kyrtsonis, Marie Christine, Tsaftaridis, Panayiotis, Karkantaris, Christos, Anargyrou, Konstantinos, Boutsis, Dimitrios E, Variamis, Eleni, Michalopoulos, Thymios, Boussiotis, Vassiliki A, Panayiotidis, Panayiotis, Papavassiliou, Constantinos, Pangalis, Gerassimos A

“…To present our long-term experience regarding the use of chemotherapy plus low-dose involved-field radiotherapy (IFRT) for clinical Stage I-IIA Hodgkin's…”
Get more information

A014 High Serum TIMP-1 Correlates with Advanced Myeloma and Poor Survival by Terpos, E, Dimopoulos, MA, Shrivastava, V, Leitzel, K, Christoulas, D, Migkou, M, Gavriatopoulou, M, Anargyrou, K, Kastritis, E, Hamer, P, Carney, W, Lipton, A

Get full text

Retrospective evaluation of the risk profile in chronic myelogenous leukemia (CML) according to a new prognostic scoring system by Terpos, E., Mantzourani, M., Stavroyianni, N., Anargyrou, K., Viniou, N., Loukopoulos, D., Yataganas, X.

Get full text

Pulmonary Balantidium coil infection in a leukemic patient by ANARGYROU, K, PETRIKKOS, G. L, SULLER, M. T. E, SKIADA, A, SIAKANTARIS, M. P, OSUNTOYINBO, R. T, PANGALIS, G, VAIOPOULOS, G

Get full text

Detection of CD55- and/or CD59-deficient red cell populations in patients with plasma cell dyscrasias by MELETIS, John, TERPOS, Evangelos, VARIAMI, Eleni, VINIOU, Nora, KONSTANTOPOULOS, Konstantinos, SAMARKOS, Michalis, MELETIS, Christos, APOSTOLIDOU, Effie, KOMNINAKA, Veroniki, KOROVESIS, Konstantinos, ANARGYROU, Konstantinos, BENOPOULOU, Olga, MAVROGIANNI, Despina

“…Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal disorder characterized by a decrease or absence of glycosylphosphatidylinositol (GPI)-anchored…”
Get full text